Inhibitor Therapeutics Market Cap

Inhibitor Therapeutics has a market cap or net worth of $15.53 million as of April 29, 2026. Its market cap has increased by 12.66% in one year.

Market Cap

15.53M

Enterprise Value

13.22M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.09

Market Cap Chart

Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 15.53M, an increase of 10.34%. That is a compound annual growth rate of 0.35%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	15.53M	100.00%
Dec 31, 2025	7.77M	-25.02%
Dec 31, 2024	10.36M	-34.56%
Dec 28, 2023	15.83M	-57.47%
Dec 28, 2022	37.21M	-34.06%
Dec 30, 2021	56.43M	332.16%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zeo ScientifiX	15.55M
Oncotelic Therapeutics	16.79M
HOOKIPA Pharma	14.15M
EOM Pharmaceuticals Holdings	17.08M
Anebulo Pharmaceuticals	19.57M
Finch Therapeutics Group	12.30M
Provectus Biopharmaceuticals	23.07M
Arch Biopartners	23.37M

Market Cap Rankings